Effects of 24-week add-on treatment with ciclesonide and montelukast on small airways inflammation in asthma.

Author: InoueHideki, ItoIsao, IwataToshiyuki, KanemitsuYoshihiro, MatsumotoHisako, MishimaMichiaki, NagasakiTadao, NakajiHitoshi, NiimiAkio, OgumaTsuyoshi, PetrovaGuergana, TajiriTomoko

Paper Details 
Original Abstract of the Article :
BACKGROUND: Eosinophilic inflammation of the small airways is a key process in asthma that often smolders in treated patients. The long-term effects of add-on therapy on the persistent inflammation in the small airways remain unknown. OBJECTIVE: To examine the effects of add-on therapy with either ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.anai.2012.12.016

データ提供:米国国立医学図書館(NLM)

Addressing Persistent Small Airways Inflammation in Asthma: Exploring Add-on Therapies

Asthma is a chronic respiratory condition that often involves [inflammation of the small airways]. This study investigates the effectiveness of add-on therapies with [ciclesonide] and [montelukast] in reducing small airways inflammation in patients with stable asthma who are already receiving inhaled corticosteroids. The researchers compared the effects of these add-on therapies over a 24-week period, finding that both treatments were beneficial in reducing inflammation and improving asthma control.

Combating Persistent Asthma Inflammation: A Multi-pronged Approach

This research provides valuable insights into the management of asthma, particularly the persistent inflammation that can occur even with standard treatment. The findings suggest that add-on therapies with ciclesonide and montelukast can effectively reduce small airway inflammation and improve asthma control. This research, like a camel caravan navigating a treacherous sandstorm, highlights the importance of a multi-pronged approach to managing this complex condition.

Living with Asthma: Managing Inflammation and Improving Quality of Life

This research offers hope for individuals with asthma, particularly those who continue to experience persistent inflammation despite standard treatment. The effectiveness of ciclesonide and montelukast as add-on therapies provides valuable options for managing this challenge and improving overall quality of life. This research, like a cool oasis in the desert, reminds us that even in the face of ongoing challenges, there are ways to find relief and manage chronic conditions effectively.

Dr.Camel's Conclusion

This research, like a seasoned camel guide leading a caravan through the desert of asthma, highlights the importance of addressing persistent small airway inflammation. It underscores the potential of add-on therapies with ciclesonide and montelukast to improve asthma control and enhance quality of life for individuals living with this chronic condition.

Date :
  1. Date Completed 2013-06-07
  2. Date Revised 2021-12-03
Further Info :

Pubmed ID

23548532

DOI: Digital Object Identifier

10.1016/j.anai.2012.12.016

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.